[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@cafepharma cafepharma

cafepharma posts on X about mon, sanofi, regeneron, philips the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

• X Week XXXXX +11%
• X Month XXXXX -XXXX%
• X Months XXXXXX +131%
• X Year XXXXXX +20%

Mentions: X #

• X Week X -XX%
• X Month XX -XX%
• X Months XX +96%
• X Year XXX +43%

Followers: XXXXXX #

• X Week XXXXXX -XXXX%
• X Month XXXXXX -XXXX%
• X Months XXXXXX -XXXX%
• X Year XXXXXX -XXXX%

CreatorRank: XXXXXXXXX #

Social Influence

Social category influence stocks technology brands

Social topic influence mon, sanofi #20, regeneron, philips, ai, $890m, $11b

Top assets mentioned Sanofi (SNY)

Top Social Posts

Top posts by engagements in the last XX hours

"Mon news: Lilly at ASH- makes case to widen Jaypirca use. Structure Therapeutics soars on obesity asset success. Viatris to sell stake in Biocon Biologics. Regeneron at ASH - Lynozyfic in myeloma. Waves promising weight loss trial"
X Link 2025-12-08T16:51Z 17.5K followers, XXX engagements

"Mon news: Sanofi suffers double setback for MS drug. Philips adding AI heart imaging with company purchase. Gilead HIV trial results. Pfizers $890M deal with Adaptive Biotech. BioSecure Act may be finally headed to Trumps desk"
X Link 2025-12-15T17:04Z 17.5K followers, XXX engagements

"Tue news: Pfizer foresees challenging 2026. Genentech and Caris in $1.1B deal for rare cancer targets. Pfizer and Sanofi in separate autoimmune pacts. Makary says no black box on COVID vaccines. AZ-Daiichi get FDA nod in first line breast cancer"
X Link 2025-12-16T17:15Z 17.5K followers, XXX engagements